Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
Intravenous Immunoglobulin Market Growth Projections and Opportunities
Myasthenia gravis (MG) is a health problem where the body's immune system causes issues with how muscles work by disrupting the communication between nerves and muscles. Often, this happens because the thymus gland is an abnormal size or because there are non-cancerous tumors on the thymus.
The growth of the market is due to factors like awareness programs, efforts by groups, and the increasing number of people with MG. More money being put into research for myasthenia gravis is also expected to help the market. However, the cost of treating MG is high and could slow down how much the market grows in the future.
The global myasthenia gravis market is predicted to reach USD 3094.10 million by 2023, compared to USD 1776.12 million in 2017. This is a growth rate of 9.61% each year from 2018 to 2023. In 2017, the Americas had the most significant part of the market at 38.9%, followed by Europe at 34.5%, and Asia-Pacific at 20.6%.
The market is split into categories based on the type of MG, how it's diagnosed and treated, who is using the products, and where in the world it is happening. When looking at the types, generalized myasthenia gravis was the most common, making up 44.7% of the market in 2017. It was valued at USD 793.98 million and is expected to grow by 11.90% each year.
When it comes to diagnosing and treating MG, treatment had the most significant part of the market in 2017 at 69.6%. Its value was USD 1236.09 million, and it's predicted to grow by 9.52% each year.
Hospitals and clinics are the most significant users of products for myasthenia gravis, making up 55.8% of the market in 2017. The value was USD 990.37 million, and it's projected to grow by 10.16% over the assessment period.
| Report Attribute/Metric | Details |
|---|---|
| Growth Rate | 7.50% (2022-2030 |
Intravenous Immunoglobulin Market Highlights:
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
